NCT00096928已完成不适用
Raptiva Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,846
- 试验地点
- 179
研究概览
简要总结
This was a multicenter, prospective, 5-year surveillance study of approximately 5000 Raptiva-treated patients and approximately 500 non-Raptiva treated patients (formerly 2500 comparison patients who were treated with a biologic therapy other than Raptiva) with chronic moderate to severe plaque psoriasis who were candidates for treatment with Raptiva.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Have ever had a physician's diagnosis of chronic moderate to severe plaque psoriasis and be a candidate for treatment with Raptiva
- •Are being treated with or initiating Raptiva therapy at the time of enrollment
- •Be able to provide written informed consent
- •Be willing and able to fully to participate for the duration of patient follow-up (5 years)
- •Exclusion Criterion:
- •Have previously received at least one dose of Raptiva and are not currently using or restarting treatment with Raptiva at the time of enrollment
排除标准
- 未提供
研究者
研究点 (179)
Loading locations...
相似试验
尚未招募
1 期
A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.Plaque PsoriasisNCT06396013Beijing Hospital of Traditional Chinese Medicine96
招募中
不适用
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)Plaque PsoriasisNCT06382987Bristol-Myers Squibb600
已完成
不适用
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric PsoriasisPsoriasisNCT01100034Pfizer72
已完成
4 期
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)Moderate Plaque PsoriasisNCT06333860AbbVie393
已完成
不适用
Hemoperfusion With Efferon CT for the Treatment of Patients With Severe PsoriasisPsoriasisNCT06640114Efferon JSC60